FDA Approves Moderna’s mRNA Flu Vaccine for Adults 50 and Older – NaturalNews.com
FDA Approves Moderna’s mRNA Flu Vaccine for Adults 50 and Older The U.S. Food and Drug Administration approved Moderna’s mRNA influenza vaccine, mFLUSIVA, for adults aged 50 and older, marking the first time the agency has licensed an mRN
